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Abstract: Like mitochondria, peroxisomes produce reactive oxygen species (ROS), compounds
which have been implicated to play an important role in many degenerative diseases
and aging itself, and an exaggerated ROS production might occur in altered or older
organelles. Growing evidence shows that autophagy, a required function in cell
housekeeping during fasting, can remove damaged macromolecules, organelles, and
membranes selectively. Proliferation of peroxisomes can be enhanced in liver cells by
pentafluorooptanoic acid (PFOA), which causes a marked increase of the Acyl CoA
oxidase (ACOX) activity and no significant change in urate oxidase (UOX) activity. The
administration of antilipolytic drugs to fasted animals was shown to intensify
autophagy. Here we tested the hypothesis that autophagy may distinguish and remove
older from younger peroxisomes in rat liver. Male Sprague¬-Dawley rats were given
PFOA (150 mg/kg body weight) or vehicle. Animals were sacrificed at different times
following PFOA administration, and 3 hours after the induction of autophagy with the
antilipolytic agent 3,5-dimethyl pyrazole (DMP, 12 mg/kg body weight). The levels of
ACOX and UOX activity were measured in the liver tissue. Results showed that
autophagy caused a parallel, significant decrease in both enzymes activity in control
rats, and that in PFOA treated rats the effects were different and changed with PFOA
time administration. Changes are compatible with the hypothesis that newly formed
ACOX-rich peroxisomes are resistant to pexophagy and that sensitivity to pexophagy
increases with increasing peroxisomal "age". In conclusion, there is indirect evidence
supporting the hypothesis that autophagy may recognize and degrade older
peroxisomes.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
To the Editor  
Molecular and Cellular Biochemistry 
 
 
 
I am glad to submit you the revised manuscript MCBI-D-16-01228 “Peroxisomes proliferation and 
pharmacological stimulation of autophagy in rat liver: evidence to support that autophagy may remove the “older” 
peroxisomes” by Alessio Donati, Michele Taddei, Ettore Bergamini and myself. 
I hope that this revised manuscript may now meet requirements made by the Reviewers and can be further 
considered for publication in Molecular and Cellular Biochemistry. Furthermore, I should mention that MCBI-D-16-
01228 was a revised version of the original manuscript MCBI-D-00915 (the manuscript had been revised to meet the 
comment of Reviewer #2 , Reviewer #1 was strongly positive and recommended acceptance and publication without 
any change; your e-mail date September 27). 
 
Thank you very much in advance for your kind consideration. 
                                                                                                                  
                                                                                                                     Kindest regards 
                                                                                                                   Gabriella Cavallini 
Cover Letter
We warmly thank reviewers for helpful comments and criticisms. 
Note for reviewing purposes - Our comments/answers in bold italic 
 
Revisions and corrections in the text all in red bold 
 
 
Reviewer #1: Authors investigated the role of autophagy in regulating hepatic peroxisome homeostasis in a rat 
model. Autophagic removal of excessive peroxisomes in yeast or mammalian cells including liver has been well 
studied. 
Reference to the first report of induced autophagic degradation of rat liver cell peroxisomes is given (ref. n. 19) 
together with one of the first reviews on pexophagy (ref. n. 18, Introduction, 4th paragraph). 
 
The novelty of this study is low. However, the idea that autophagy may selectively remove old peroxisome in 
preference of new peroxisome is interesting. 
We agree with the comment that the novelty of this study is the proposal that pexophagy in mammalian cells may be 
selective, like the case of mitophagy (ref. n.7,8) and that in both cases older (possibly defective) organelles may be 
removed and degraded preferentially. 
 
However, this study is largely descriptive and data were not convincing enough to support the conclusion. There will be 
very limited advance in our understanding of peroxphagy from this study. 
This is intended to be a preliminary communication, for  this reason the paper has been submitted as “ Short 
communication”. We agree that this experimental model may deserve further exploration, but these results may be 
an additional step towards understanding mechanisms underlying selective autophagic degradation of partially 
dysfunctional peroxisomes in mammals, probably the oldest ones. In addition, our in vivo model might indicate a 
new promissory avenue for community of researchers working on underlying mechanisms of peroxisomes turnover. 
 
Maior concerns: 
 
1. The authors claimed that DMP can induce autophagy in the liver. More biochemical data from the liver such as 
morphological for autophagosomes or biochemically for autophagy markers such as LC3 and p62 should be provided. 
Evidence showing that DMP can induce autophagy in the liver is sound and the underlying endocrine mechanisms 
have been fully elucidated. References are given (ref. n.7,19,20,32,38). 
Biochemical data from the liver such as morphological data for autophagosomes at the electron microscopy level 
(TEM) can be found in Locci Cubeddu et al.( ref. n.19 ). Now reference to this paper is emphasized (Introduction, 4th 
paragraph). 
Morphological data for autophagosomes and biochemical data for autophagy marker such as LC3 can be found in 
Donati et al. (ref. n. 32). 
 
2. In figure 2, the authors showed increased ACOX activity after PFOA treatment in Day 2 and 4. However, In figure 4, 
no such increase were shown. There was no explanation for such discrepancy. 
In figure 2, we showed the effects of PFOA administration for 2 and 4 days on the content of ACOX) activity. 
Results were given as percent changes with respect to not-PFOA treatment and the increase of ACOX activity with 
PFOA time administration was shown. 
In figure 4, we showed the effect of DMP treatment and PFOA administration. Results were given as percent 
changes with respect to not-DMP treatment, therefore the columns PFOA 2d and PFOA 4d represented the total 
effect of PFOA (100/100) respectively. Unit of enzyme activity (μmol NAD+ reduced/min) in the whole liver were : 
9.8 in NO PFOA; 78 in PFOA 2d; 152 in PFOA 4d. 
 
3. The manuscript was poorly written and many references on perxophagy were not cited. 
More references on pexophagy are given (ref. n. 9,10,18,,27,30,31,36,37). 
 
 
 
 
 
 
 
 
Reviewer #2: The authors describe their work on autophagy of peroxisomes in the liver. They found that autophagy 
might recognize and degrade older peroxisomes. This is an interesting study. Appropriate methodology has been 
Response to Reviewer Comments
employed and the conclusions appear to be justified based on the data at hand. I have a few minor points for 
consideration. 
We thank the Reviewer for her/his positive comment. 
 
Minor points: 
 
1. Please move section on ethical approval to the methods section. 
Section on ethical approval was moved to the methods section as suggested. 
 
2. Please combine results and discussion sections together. 
Results and discussion were combined into one section as suggested. 
 
3. The authors should discuss further the mechanisms of peroxisome turnover in relation to peroxisomal disorders, the 
role of peroxisomes in age-related diseases and the process of aging.  
The mechanism of peroxisome turnover in relation to peroxisomal disorders, the role of peroxisomes in age-related 
diseases and the process of aging were discussed further (Results and Discussion, p. 7, last thirteen line; p. 8, lines 1-
6). 
 
4.The authors need to elaborate on the clinical applicability/relevance of the study findings 
The clinical applicability/relevance of the study findings was highlighted (Results and Discussion, p. 7, last line; p. 8, 
lines 1-6). 
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Abstract 
 
Like mitochondria, peroxisomes produce reactive oxygen species (ROS), compounds which have been implicated to 
play an important role in many degenerative diseases and aging itself, and an exaggerated ROS production might occur 
in altered or older organelles. Growing evidence shows that autophagy, a required function in cell housekeeping during 
fasting, can remove damaged macromolecules, organelles, and membranes selectively. Proliferation of peroxisomes can 
be enhanced in liver cells by pentafluorooptanoic acid (PFOA), which causes a marked increase of the Acyl CoA 
oxidase (ACOX) activity and no significant change in urate oxidase (UOX) activity. The administration of antilipolytic 
drugs to fasted animals was shown to intensify autophagy. Here we tested the hypothesis that autophagy may 
distinguish and remove older from younger peroxisomes in rat liver. Male Sprague-Dawley rats were given PFOA (150 
mg/kg body weight) or vehicle. Animals were sacrificed at different times following PFOA administration, and 3 hours 
after the induction of autophagy with the antilipolytic agent 3,5-dimethyl pyrazole (DMP, 12 mg/kg body weight). The 
levels of ACOX and UOX activity were measured in the liver tissue. Results showed that autophagy caused a parallel, 
significant decrease in both enzymes activity in control rats, and that in PFOA treated rats the effects were different and 
changed with PFOA time administration. Changes are compatible with the hypothesis that newly formed ACOX-rich 
peroxisomes are resistant to pexophagy and that sensitivity to pexophagy increases with increasing peroxisomal “age”. 
In conclusion, there is indirect evidence supporting the hypothesis that autophagy may recognize and degrade older 
peroxisomes. 
 
 
 
 
 
 
 
 
 
 
Keywords: Peroxisomes, Autophagy, Pentafluorooptanoic acid, Antilipolytic drugs, Aging, Rat liver 
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Introduction 
 
Peroxisomes and mitochondria are the major sites for oxygen utilization and potential causes of ROS generation [1]. 
These cellular organelles are especially prone to oxidative damage resulting in a vicious circle in which the ROS 
production and oxidative damage might increase with the increasing number of older organelles in cells [2, 3]. A sign of 
aging is a rising amount of altered cellular components which may be a consequence of chronological loss of cellular 
quality control. Autophagy is a cellular process which removes proteins, cytomembranes and organelles and allows a 
continuous turnover of all cell components [4]. Several types of autophagic systems have been described based on the 
nature of sequestered material (e.g. mitophagy, pexophagy, aggrephagy, lipophagy etc.) [5], that fulfill two main 
functions inside cells: acting as an alternative source of energy and participating in cellular quality control [6]. 
Mitophagy in mammalian cell was proposed to be responsible for targeting and degrading altered mitochondria rich in 
mtDNA mutations [7, 8]. Increasing lines of evidence suggest that selective pexophagy plays a major role in mediating 
peroxisomal quality control in yeast species and mammalian cells [9, 10]. 
Peroxisomes are abundant and dynamic organelles that can rapidly modulate their size number, and enzyme content in 
response to nutritional and environmental stimuli [11, 12]. It was shown that in mammalian cells newly synthesized 
peroxisomes arise by a de novo pathway from the ER, with only a minor fraction being formed by fission of preexisting 
organelles [13]. Studies in rodents showed a rapidly proliferation and degradation upon the administration and 
subsequent withdrawal of a variety of xenobiotics, collectively known as peroxisome proliferators [14, 15]. PFOA is a 
peroxisome proliferator-activated receptor (PPAR) agonist which stimulates proliferation of peroxisomes resulting in a 
marked increase in ACOX activity with no change in UOX [16]. Therefore, the “new” PFOA-induced peroxisomes 
might be richer in ACOX than “older” peroxisomes and the induction might cause unbalanced changes in enzyme 
activity secondary to a transient heterogeneity into the peroxisomal population [17].  
In this research, we test the hypothesis that pexophagy may preferentially distinguish and remove older from 
younger peroxisomes in rat liver by the use of an experimental model consisting in the induction of peroxisome 
proliferation followed by a timed stimulation of the autophagic degradation of  peroxisomes, named pexophagy [18]. 
This model of autophagic stimulation was proposed and validated with biochemical and morphological techniques [19].  
Proliferation of peroxisomes was induced by the administration of PFOA and pexophagy was stimulated in fasted rats 
by the injection of DMP, an antilipolityc agent, as described by Donati et al. [20]. In view of the time-lag of the 
peroxisome proliferation after the administration of PFOA [21] and the estimated half-life of liver peroxisomes [22], 
changes in the ratio of PFOA-inducible acyl CoA oxidase to PFOA-not-inducible urate oxidase enzymes activities were 
monitored 2 and 4 days following the administration of PFOA, and 3-hours after the injection of DMP. 
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Materials and methods 
 
Materials 
 
All reagents were of analytical and HPLC grade. Solvents were purchased from Panreac Química S.L.U. (Barcelona, 
Spain). Standard molecules and chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). Milli-Q 
(Millipore-Lab, Bedford, MA, USA) purified water was used for all analyses. 
 
Animals 
 
Male Sprague-Dawley rats of 2-month of age were supplied by the Pisa University Interdepartmental Research Centre 
on Biology and Pathology of Aging vivarium. All of the experiments were conducted following the Official Italian 
Regulation n. 116/92 for the care and use of laboratory animals. All handing and management procedures were 
approved by the Independent Ethics Committee of the University of Pisa (Approval number: 2A/42155). Animals were 
kept in a controlled environment (22 °C, 12/12 h light/dark cycle), fed with a standard laboratory diet (Teklad, Harlan, 
Italy), and had free access to water. Rats were treated intragastrically with PFOA at 150 mg/kg body weight in 0.5 mL 
corn oil, or with an equal volume of vehicle alone, 48 or 96 hours before sacrifice. Autophagy was induced in overnight 
fasted rats by an intraperitoneal injection of DMP at 12 mg/Kg body weight in 0.2 mL saline 3 hours before sacrifice. 
Controls were injected with vehicle alone. 
At designated time-points, rats were sacrificed under pentobarbital anesthesia (50 mg/kg body weigh, i.p.) and blood 
samples were collected from the posterior vena cava into test tube containing 0.25 M EDTA. Subsequently, livers were 
perfused with ice-cold saline via the portal vein to remove blood, surgically isolated, snap frozen in liquid nitrogen, and 
stored at – 80 °C until analyzed. 
 
High-pressure liquid chromatography (HPLC) assay of plasma valine 
 
The stimulatory effect of DMP on the rate of liver autophagic proteolysis was monitored by assaying the levels of 
plasma valine by HPLC as described in [20]. Amino acid separation was carried out on a 4.6 x 250 mm Bio-Sil ODS-5S 
column (particle size, 5 mm) in a Beckman HPLC system (equipped with 32 Karat software). Valine was determined by 
measuring the fluorescence of its dansylated derivative with a Jasco spectrofluorometer (340 nm excitation, 525 
emission). Norvaline was added as an internal standard to all samples. Results are given as nmol valine/mL plasma. 
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Assay of acyl CoA oxidase and urate oxidase 
 
Tissue samples were homogenized (20%, w/v) in ice-cold 0.25 M sucrose. Acyl-CoA oxidase activity was assayed by 
measuring the increase in absorbance at 340 nm resulting from cyanide-insensitive palmitoyl-CoA dependent NAD+ 
reduction as described in [23] with some modifications as described in [24]. Results are given as unit of enzyme activity 
(μmol NAD+ reduced/min) in the whole liver. Urate oxidase activity was assayed by measuring the decrease in 
absorbance at 290 nm resulting from the oxidation of uric acid to allantoin as described in [25]. Results are given as unit 
of enzyme activity (μmol uric acid disappeared/min) in the whole liver. 
 
Statistical analysis 
 
The analysis of variance (ANOVA) test was used to evaluate differences among multiple conditions. If positive, the 
Tukey test was used to test for their statistical significance. Values of p < 0.05 were considered to be statistically 
significant. 
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Results and Discussion 
 
Both mitochondria and peroxisomes are recognized and degraded by selective processes of autophagy named 
mitophagy and pexophagy respectively [26, 27]. It was shown that mitophagy specifically targets and removes the more 
severely damaged mitochondria, probably the oldest ones [28, 29]. 
 In this research we tested the hypothesis that autophagy/pexophagy too may distinguish and remove older from 
younger peroxisomes in rat liver by the use of an experimental model consisting in the induction of peroxisome 
proliferation followed by timely pharmacological stimulation of autophagy. To our knowledge, no previous report can 
be found, indicating specificity for older peroxisomes of the autophagic machinery, which is usually reported to 
eliminate redundant organelles [30, 31].  
As expected, PFOA administration induced a progressive increase in the liver/body weight ratio (2 days: + 30 %, 4 
days: + 70 %, Fig. 1) and caused dramatic changes in peroxisomal enzyme activities compatible with a transient 
heterogeneity into the peroxisomal population, with an enrichment in “younger” ACOX-rich as compared to “older” 
relatively ACOX-poor peroxisomes [16, 17]. The effects of PFOA administration on UOX and ACOX activities 
exhibited different temporal patterns: total UOX activity in the liver showed small changes, while ACOX activity 
increased dramatically (eight-and fifteen-fold, after 2 and 4 days respectively, Fig. 2) . A previous study had shown that 
the maximum increase in the concentration of peroxisomal β-oxidation activity in rat liver is achieved within 48 hours 
after PFOA treatment and that the maximum accumulation of ACOX activity in the whole liver can be expected by day 
3 [21]. 
The stimulatory effect of  the administration of DMP on autophagic proteolysis was monitored by studying the changes 
in the plasma levels of valine [32], and was similar in control and PFOA-treated rats (Fig. 3). As expected, treatment 
had very rapid effects on the peroxisomal population both in control and in PFOA treated rats. In control (NO PFOA) 
animals, the decreases in UOX and ACOX activity (30% and 25%, respectively) after treatment with DMP were similar 
in agreement with previous observation [19], but in PFOA-treated rats the effects were different and changed with the 
given enzyme and the time after PFOA administration. In fact, 2 days after PFOA treatment, the DMP-induced 
stimulation of pexophagy caused a 30 % decrease in UOX activity similar to that in NO PFOA rats, but no significant 
changes in ACOX activity; whereas the same treatment in 4 days PFOA given rats caused minor, not significant, 
changes in UOX activity  and a marked decrease (30%) in ACOX activity (Fig. 4). The ACOX/UOX activity ratio 
highlights the differences in the effect of DMP injection after PFOA treatment on peroxisomal enzyme activities likely 
to reflect changes in the composition of the peroxisomal population proner to degradation: in PFOA-treated rats, DMP-
induced pexophagy caused a slight increase in the ACOX/UOX ratio by day 2, a highly significant decrease  in the ratio 
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by day 4 (Fig. 5). It may be worthwhile to keep in mind here that the maximum recorded decrease in peroxisome-
enzyme activities was about 30%, both in control and PFOA treated rats, and that Huybrechts et al. have shown that 
peroxisomes in cultured mammalian cells have a half-life of approximately 2 days and a daily fractional peroxisomal 
turnover rate of approximately 30% [33]. Furthermore, it was shown that autophagy pathway(s) may play a major role 
in the degradation of recombinant rat UOX, and that the entire organelle rather than a single protein within the 
peroxisomes may be degraded [34].  
In view of the facts that number, size, and enzyme content of peroxisome may vary dramatically in response to 
changes in cellular demands or after the administration of peroxisome proliferators [11, 15]; that the administration of  
PFOA triggers peroxisome proliferation and induces peroxisomal beta-oxidation in rats [21] and mice [35] in less than 
one day but may not induce urate oxidase or catalase; that rats raised on a controlled and highly fixed environment (like 
NO PFOA animals) exhibit a homogenous population of peroxisomes, while a chemical proliferator can generate a 
marked polydispersity of peroxisomes [17] it is conceivable that the differences reported here might be secondary to 
time-related changes in older peroxisomes to be degraded, that could be recognized by the pexophagy machinery. 
Evidence is accumulating that damaged peroxisomes are subject to rapid autophagic degradation after that one or more 
proteins are exposed at the surface of these organelles [36, 37]. Perhaps an increase in ACOX activity without any 
parallel increase in catalase activity might expose organelles to a higher oxidative injury. In this perspective and in line 
with the case of mitophagy [7], our data might invite the speculation that pexophagy can recognize “older”, altered  
organelles to preserve suitable quality. 
Finally, since treatment with antilipolityc agent can boost the antiaging effects of caloric restriction [38] by intensifing 
the physiological response to fasting (i.e. the decrease in blood glucose and insulin and the increase in glucagon and 
corticosteroids plasma levels [32]), there is support to the hypothesis that accumulation of “older” possibly defective 
organelles in older cells might take part in the process of aging. Thus, in line with the case of mitophagy, it is 
conceivable that also a precise removal of aged peroxisomes by pexophagy is required for the maintenance of cellular 
homeostasis [39]. Further studies are undoubtedly needed to understand how the older peroxisomes communicate with 
the autophagic machinery in order to promote peroxisomal quality control into physiological cellular processes. 
Perhaps, the longer is the organelle’s life and the exposure of membrane proteins to the generated ROS, the higher is the 
level of altered organelle’s proteins to be ubiquitinated and then detected by the autophagosome membrane as suggested 
by Schrader et al. [40].  
A recent study highlights the role of redox communication between peroxisomes and mitochondria into cellular 
communication networks during cellular and organismal aging [41]. This interplay may be involved into the 
etiopathogenesis of peroxisomal disorders, like X-linked adrenoleukodystrophy [42]. In this perspective, since treatment 
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with antilipolytic during fasting was shown to induce autophagy and be beneficial in humans [43, 44], perhaps it might 
deserve to be tested on the innate and acquired peroxisomal defects that can result in a large variety of human 
peroxisomal disorders [45].  
In conclusion, the safe pharmacological stimulation of pexophagy by antilipolytic agents might be exploited to 
understand the mechanisms of peroxisome turnover, both in health, aging and diseases like human peroxisomal or age-
related disorders [46, 47]. 
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Figure captions 
 
Fig. 1 Effects of PFOA administration for 2 and 4 days on liver/body weight ratio. Results are given as percent changes 
with respect to not-PFOA treatment. Results represent the mean ± SEM of five cases. Value in NO PFOA was: 2.86 ± 
0.03. ANOVA statistical analysis showed that effects of PFOA administration were significant (p < 0.01). Post-
ANOVA Tukey test (p < 0.05): *versus 0 days; °versus 2 days 
 
Fig. 2 Effects of PFOA administration for 2 and 4 days on the content of urate oxidase activity (UOX) and Acyl-CoA 
oxidase activity (ACOX) in the whole rat liver. Results are given as percent changes with respect to not-PFOA 
treatment. Results represent the mean ± SEM of five cases. Values in NO PFOA were: UOX 19.5 ± 0.3 μmol uric acid 
disappeared/min; ACOX 9.8 ± 0.4 μmol NAD+ reduced/min. ANOVA statistical analysis showed that effects of PFOA 
administration on ACOX activity were significant (p < 0.01). Post-ANOVA Tukey test (p < 0.05): *versus 0 days; 
°versus 2 days 
 
Fig. 3 Effects of DMP injection and PFOA administration for 2 and 4 days on plasma levels of valine. Results are given 
as nmol valine/mL plasma. Results represent the mean ± SEM of five cases. Two-way ANOVA statistical analysis 
(DMP x PFOA): DMP main effect: (p < 0.01); PFOA main effect  (p < 0.05); DMP by PFOA interaction: N.S. Post-
ANOVA Tukey test (p < 0.05): DMP - versus DMP + 
 
Fig. 4 Effects of DMP injection and PFOA administration for 2 and 4 days on the content of urate oxidase activity 
(UOX) and Acyl-CoA oxidase activity (ACOX) in the whole rat liver. Results are given as percent changes with respect 
to not-DMP treatment. Results represent the mean ± SEM of five cases. Two-way ANOVA statistical analysis (DMP x 
PFOA): UOX: DMP main effect: (p < 0.01); PFOA main effect (p < 0.01); DMP by PFOA interaction (p < 0.01). Post-
ANOVA Tukey test (p < 0.05): DMP - versus DMP + 
ACOX: DMP main effect: (p < 0.01); PFOA main effect (p < 0.01); DMP by PFOA interaction (p < 0.01). Post-
ANOVA Tukey test (p < 0.05): DMP - versus DMP + 
 
Fig. 5 Effects of DMP injection and PFOA administration for 2 and 4 days on the of Acyl-CoA oxidase (ACOX)/urate 
oxidase (UOX) activity ratio in the whole rat liver. Results represent the mean ± SEM of five cases. Two-way ANOVA 
statistical analysis (DMP x PFOA): DMP main effect: (p < 0.01); PFOA main effect  (p < 0.01); DMP by PFOA 
interaction: (p < 0.01). Post-ANOVA Tukey test (p < 0.05): DMP - versus DMP +; *versus 0 days; °versus 2 days 
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